ストックスクリーナーアプリを入手
130.32
2.65%
3.36
アフターアワーズ：
129.72
-0.60
-0.46%
前日終値:
$126.96
開ける：
$126.79
24時間の取引高:
1.14M
Relative Volume:
0.59
時価総額：
$19.80B
収益：
$4.34B
当期純損益:
$850.00M
株価収益率:
23.85
EPS:
5.4635
ネットキャッシュフロー:
$921.00M
1週間 パフォーマンス:
+3.07%
1か月 パフォーマンス:
+9.57%
6か月 パフォーマンス:
+43.21%
1年 パフォーマンス:
+73.62%
1日の値動き範囲:
$126.49
$130.79
1週間の範囲:
$118.30
$132.79
52週間の値動き範囲:
$69.83
$155.53
Illumina Inc Stock (ILMN) Company Profile
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
130.32 | 18.37B | 4.34B | 850.00M | 921.00M | 5.4635 |
TMO
Thermo Fisher Scientific Inc
|
527.22 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
198.61 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
584.05 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
120.39 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
330.98 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-12 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 繰り返されました | Citigroup | Neutral |
| 2025-02-28 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-02-10 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-02-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-11-12 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-10-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-08-28 | アップグレード | Argus | Hold → Buy |
| 2024-08-16 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-08-14 | アップグレード | TD Cowen | Hold → Buy |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-01-16 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-01-04 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-12-11 | アップグレード | Citigroup | Sell → Neutral |
| 2023-11-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 開始されました | Bernstein | Underperform |
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-25 | ダウングレード | Argus | Buy → Hold |
| 2023-01-05 | 開始されました | Scotiabank | Sector Perform |
| 2022-12-12 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-04 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-07-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-01-18 | アップグレード | Stifel | Hold → Buy |
| 2022-01-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-01-07 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-19 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-03-31 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 開始されました | Barclays | Underweight |
| 2020-12-22 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-10-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | ダウングレード | Stifel | Buy → Hold |
| 2020-09-22 | ダウングレード | UBS | Buy → Neutral |
| 2020-09-21 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-09-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-08-07 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2020-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-04-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-04-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-10-25 | 開始されました | Guggenheim | Buy |
すべてを表示
Illumina Inc (ILMN) 最新ニュース
How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership - simplywall.st
Illumina partners with D3b on pediatric genomic data initiative - Investing.com
Illumina Partners with D3b to Advance Pediatric Cancer Research - Intellectia AI
100,000 child genomes power rare disease and cancer research - Stock Titan
Third View Private Wealth LLC Buys Shares of Illumina, Inc. - National Today
Administrator Loeffler Applauds SBIR-STTR Reauthorization - GlobeNewswire Inc.
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Hardman Johnston Trims Illumina Stake - National Today
Bioinformatics Market 2026- 2033 Overview: Share, Size, Value, - openPR.com
Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration - Insider Monkey
Epigenetics Market to Grow from US$ 2.06 Billion in 2024 to US$ - openPR.com
Illumina Inc. stock (US4523271090): Is its genomics leadership strong enough for long-term U.S. inve - AD HOC NEWS
Is It Time To Reassess Illumina (ILMN) After Its 61.7% One Year Share Price Rebound - Yahoo Finance
Is Illumina Stock Undervalued at $121? - TIKR.com
Illumina Inc stock (US4523271090): Is its genomics dominance strong enough to unlock new upside? - AD HOC NEWS
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Illumina Stock: Competitive Threats Priced In (NASDAQ:ILMN) - Seeking Alpha
Illumina Inc (ILMN) Stock Down 3.4% -- Now Undervalued? GF Score: 83/100 - GuruFocus
Informatics advances reveal the TruPath™ Genome towards comprehensive genomic insights - Illumina
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 - marketscreener.com
Illumina Inc. stock rises Wednesday, still underperforms market - MarketWatch
(ILMN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance
New Zealand gains genomic testing independence - Illumina
Illumina, Inc. $ILMN Shares Sold by Aberdeen Group plc - MarketBeat
The Evolving Landscape of Proteomics: HUPO World Congress Interview with Professor Stuart Cordwell - Illumina
Illumina rejigs board of directors - Medical Buyer
Cathie Wood's Called It Years Ago – Illumina Is the Must-Own Personalized Biotech Stock - Money Morning
Illumina, Inc. (ILMN) stock price, news, quote and history - Yahoo Finance Singapore
Illumina Inc (ILU.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Illumina, Inc. (ILMN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Illumina Stock Hits Day Low of $116.75 Amid Price Pressure - Markets Mojo
Cancer Biopsy Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Liquid Biopsy Products Market Is Going to Boom | Illumina • Biocept • Natera • Roche - openPR.com
Illumina, Inc. (ILMN) latest stock news and headlines - Yahoo Finance Singapore
Illumina adds King to board as three directors retire By Investing.com - Investing.com Australia
Illumina Announces Changes to Board of Directors - The Malaysian Reserve
Illumina (ILMN) director Scott Ullem takes 2026 retainer as 190 ILMN shares - Stock Titan
Illumina (NASDAQ: ILMN) director paid in stock, linked to Corvex funds - Stock Titan
Illumina's 'Obvious Mistake' Not Enough To Chuck UPC Claim - Law360
UPC refuses early knockout in Illumina–Element dispute - Life Sciences Intellectual Property Review
Illumina, Inc. Announces Board Retirements, Effective May 21, 2026 - marketscreener.com
Illumina adds King to board as three directors retire - Investing.com
Illumina Announces Board Retirements and New Director Nominee - TipRanks
Illumina (NASDAQ: ILMN) nominates David P. King as three directors retire - Stock Titan
AAV Genome Sequencing Service Market Is Booming Rapidly with - openPR.com
Exosome Research Market is Thriving Worldwide | Thermo Fisher Scientific, Illumina Inc, Miltenyi Biotec, QIAGEN - openPR.com
An Illumina milestone powered by our people: 100,000 volunteer hours - Illumina
Illumina Inc (ILMN) 財務データ
収益
当期純利益
現金流量
EPS
0.65%
0.32%
大文字化:
|
ボリューム (24 時間):